Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results

NCT04060485 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04060485
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04060485 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 19, 2019
Completion date
December 31, 2024
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, aplastic anemia, myelodysplastic syndromes, myeloproliferative neoplasm